Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipilimumab vs dacarbazine in chemotherapy-naive advanced melanoma (China)
CTR20150703Phase 3Active
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of ipilimumab in melanoma, sponsored by Bristol Myers Squibb. Started Oct 2015; status: active.
02
Drugs
ipilimumab
03
Conditions
melanoma
Beyond the preview
Go deeper on CTR20150703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150703.